NCT02487706View on ClinicalTrials.gov

Assessment of Dolutegravir Removed by Hemodialysis in HIV-infected Patients With End-stage Renal Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
HIV
Interventions
DRUG

Dolutegravir

Dolutegravir 50mg/day per 5 days

Trial Locations (1)

08916

Germans Trias i Pujol Hospital, Badalona

All Listed Sponsors
lead

Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia

OTHER

NCT02487706 - Assessment of Dolutegravir Removed by Hemodialysis in HIV-infected Patients With End-stage Renal Disease | Biotech Hunter | Biotech Hunter